LEE'S PHARMACEUTICAL HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.16 HKD | 0.00% |
|
-1.69% | -24.18% |
| Sales 2023 | 1.05B 134M | Sales 2024 * | 1.28B 163M | Capitalization | 683M 87.22M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 0.86 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.53 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 1,060 |
| Yield 2023 * |
-
| Yield 2024 * |
2.59% | Free-Float | 31.88% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -1.69% | ||
| Current month | -2.52% | ||
| 1 month | -7.20% | ||
| 3 months | -17.73% | ||
| 6 months | -8.66% | ||
| Current year | -24.18% |
1 week
1.13
1.16
1 month
1.121.28
Current year
1.121.52
1 year
1.121.75
3 years
1.125.85
5 years
1.1211.00
10 years
1.1215.40
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 97-03-31 | |
Xiao Yi Li
FOU | Founder | 62 | 93-12-31 |
Siu Fong Lee
CHM | Chairman | 67 | 97-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 22-01-01 |
Yau Ching Chan
BRD | Director/Board Member | 61 | 02-01-13 |
Xiao Yi Li
FOU | Founder | 62 | 93-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 1.16 | 0.00% | 0 |
| 24-04-17 | 1.16 | 0.00% | 7,500 |
| 24-04-16 | 1.16 | 0.00% | 0 |
| 24-04-15 | 1.16 | -1.69% | 58,000 |
| 24-04-12 | 1.18 | 0.00% | 63,500 |
Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT
More quotes
Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
1.16
HKD
Average target price
1
HKD
Spread / Average Target
-13.79%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.18% | 87.22M | |
| +27.97% | 676B | |
| +23.58% | 554B | |
| -7.02% | 349B | |
| +14.85% | 318B | |
| +6.25% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- 950 Stock
